{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:42:10Z","timestamp":1778712130978,"version":"3.51.4"},"reference-count":74,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007631","name":"Canadian Institute for Advanced Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007631","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["148369"],"award-info":[{"award-number":["148369"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.tmrv.2023.150748","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T02:23:02Z","timestamp":1689214982000},"page":"150748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Biphosphoglycerate Mutase: A Novel Therapeutic Target for Malaria?"],"prefix":"10.1016","volume":"37","author":[{"given":"Alessia","family":"Azzuolo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunxiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Berghuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nassima","family":"Fodil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0114-1978","authenticated-orcid":false,"given":"Philippe","family":"Gros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2023.150748_bib0001","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1182\/blood-2005-04-1622","article-title":"The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis","volume":"106","author":"van Wijk","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2023.150748_bib0002","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.placenta.2005.08.010","article-title":"Novel placental expression of 2,3-bisphosphoglycerate mutase","volume":"27","author":"Pritlove","year":"2006","journal-title":"Placenta"},{"key":"10.1016\/j.tmrv.2023.150748_bib0003","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1039\/c3cp53935k","article-title":"Insights into the phosphatase and the synthase activities of human bisphosphoglycerate mutase: a quantum mechanics\/molecular mechanics simulation","volume":"16","author":"Chu","year":"2014","journal-title":"Phys Chem Chem Phys"},{"key":"10.1016\/j.tmrv.2023.150748_bib0004","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nchembio.2453","article-title":"Bisphosphoglycerate mutase controls serine pathway flux via 3-phosphoglycerate","volume":"13","author":"Oslund","year":"2017","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.tmrv.2023.150748_bib0005","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/ncomms2759","article-title":"Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation","volume":"4","author":"Hitosugi","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.tmrv.2023.150748_bib0006","doi-asserted-by":"crossref","first-page":"39132","DOI":"10.1074\/jbc.M405982200","article-title":"Crystal Structure of Human Bisphosphoglycerate Mutase","volume":"279","author":"Wang","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tmrv.2023.150748_bib0007","doi-asserted-by":"crossref","first-page":"39642","DOI":"10.1074\/jbc.M606421200","article-title":"Seeing the process of histidine phosphorylation in human bisphosphoglycerate mutase","volume":"281","author":"Wang","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tmrv.2023.150748_bib0008","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/978-3-030-41769-7_14","article-title":"Hemoglobin: structure, function and allostery","volume":"94","author":"Ahmed","year":"2020","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.tmrv.2023.150748_bib0009","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1021\/acsmedchemlett.2c00181","article-title":"Novel Bis-phosphoglycerate Mutase modulators for treating sickle cell disease","volume":"13","author":"Sabnis","year":"2022","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.tmrv.2023.150748_bib0010","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/237146a0","article-title":"X-ray diffraction study of binding of 2,3-diphosphoglycerate to human deoxyhaemoglobin","volume":"237","author":"Arnone","year":"1972","journal-title":"Nature"},{"key":"10.1016\/j.tmrv.2023.150748_bib0011","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000209615","article-title":"Studies in congenital non-spherocytic haemolytic anaemias with specific enzyme defects","volume":"31","author":"Bowdler","year":"1964","journal-title":"Acta Haematol"},{"key":"10.1016\/j.tmrv.2023.150748_bib0012","first-page":"1147","article-title":"Congenital non-spherocytic hemolytic anemia by 2,3-diphosphoglycerate mutase deficiency of the erythrocytes in early infancy","volume":"43","author":"Schroter","year":"1965","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.tmrv.2023.150748_bib0013","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1182\/blood.V51.6.1107.1107","article-title":"Study of a kindred with partial deficiency of red cell 2,3-diphosphoglycerate mutase (2,3-DPGM) and compensated hemolysis","volume":"51","author":"Travis","year":"1978","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2023.150748_bib0014","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1172\/JCI109218","article-title":"The first case of a complete deficiency of diphosphoglycerate mutase in human erythrocytes","volume":"62","author":"Rosa","year":"1978","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tmrv.2023.150748_bib0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ajh.20014","article-title":"Erythrocytosis due to bisphosphoglycerate mutase deficiency with concurrent glucose-6-phosphate dehydrogenase (G-6-PD) deficiency","volume":"75","author":"Hoyer","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2023.150748_bib0016","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.3324\/haematol.2014.109306","article-title":"Erythrocytosis associated with a novel missense mutation in the BPGM gene","volume":"99","author":"Petousi","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2023.150748_bib0017","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/bjh.17223","article-title":"Uniparental disomy (UPD) of a novel bisphosphoglycerate mutase (BPGM) mutation leading to erythrocytosis","volume":"192","author":"Lazana","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2023.150748_bib0018","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.3324\/haematol.2016.144063","article-title":"Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations","volume":"101","author":"Camps","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2023.150748_bib0019","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1182\/blood.V80.10.2643.2643","article-title":"Compound heterozygosity in a complete erythrocyte bisphosphoglycerate mutase deficiency","volume":"80","author":"Lemarchandel","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2023.150748_bib0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/bjh.18485","article-title":"Heterozygosity for bisphosphoglycerate mutase deficiency expressing clinically as congenital erythrocytosis: A case series and literature review","volume":"200","author":"van Dijk","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2023.150748_bib0021","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/ajh.25150","article-title":"Genotype-Phenotype Correlation of Hereditary Erythrocytosis Mutations, a single center experience","volume":"93","author":"Oliveira","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2023.150748_bib0022","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3324\/haematol.2021.280516","article-title":"Erythrocytosis associated with EPAS1(HIF2A), EGLN1(PHD2), VHL, EPOR or BPGM mutations: The Mayo Clinic experience","volume":"107","author":"Gangat","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2023.150748_bib0023","doi-asserted-by":"crossref","first-page":"e53785","DOI":"10.1371\/journal.pone.0053785","article-title":"Proline: the distribution, frequency, positioning, and common functional roles of proline and polyproline sequences in the human proteome","volume":"8","author":"Morgan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tmrv.2023.150748_bib0024","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3324\/haematol.2009.008417","article-title":"Hematocrit and risk of venous thromboembolism in a general population. The Tromso study","volume":"95","author":"Braekkan","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2023.150748_bib0025","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1038\/s41375-021-01290-6","article-title":"JAK2 unmutated erythrocytosis: current diagnostic approach and therapeutic views","volume":"35","author":"Gangat","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.tmrv.2023.150748_bib0026","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2023.150748_bib0027","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-pathmechdis-012418-012838","article-title":"Pathophysiology of sickle cell disease","volume":"14","author":"Sundd","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.tmrv.2023.150748_bib0028","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3389\/fphys.2020.00435","article-title":"Recent advances in the treatment of sickle cell disease","volume":"11","author":"Salinas Cisneros","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.tmrv.2023.150748_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108170","article-title":"Bisphosphoglycerate mutase deficiency protects against cerebral malaria and severe malaria-induced anemia","volume":"32","author":"Xu","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.tmrv.2023.150748_bib0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ni.3581","article-title":"USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammation","volume":"18","author":"Torre","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.tmrv.2023.150748_bib0031","first-page":"s53","article-title":"Oxygen-linked modulation of erythrocyte metabolism: State of the art","volume":"8 Suppl 3","author":"Castagnola","year":"2010","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tmrv.2023.150748_bib0032","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1038\/s41467-022-30133-w","article-title":"Malaria in 2022: Increasing challenges, cautious optimism","volume":"13","author":"Jagannathan","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.tmrv.2023.150748_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173098","article-title":"Evidence that agricultural use of pesticides selects pyrethroid resistance within Anopheles gambiae s.l. populations from cotton growing areas in Burkina Faso, West Africa","volume":"12","author":"Hien","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.tmrv.2023.150748_bib0034","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"C. Tracking Resistance to Artemisinin. Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2023.150748_bib0035","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/cid\/ciw388","article-title":"Declining efficacy of artemisinin combination therapy against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The role of parasite genetic factors","volume":"63","author":"Phyo","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmrv.2023.150748_bib0036","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","article-title":"Evidence of artemisinin-resistant malaria in Africa","volume":"385","author":"Balikagala","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2023.150748_bib0037","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1515257","article-title":"Seven-Year Efficacy of RTS,S\/AS01 Malaria Vaccine among Young African Children","volume":"374","author":"Olotu","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2023.150748_bib0038","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-pathmechdis-012419-032640","article-title":"New insights into malaria pathogenesis","volume":"15","author":"Moxon","year":"2020","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.tmrv.2023.150748_bib0039","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrmicro.2016.79","article-title":"Plasmodium species: master renovators of their host cells","volume":"14","author":"de Koning-Ward","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.tmrv.2023.150748_bib0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.femsim.2004.01.010","article-title":"Molecular aspects of malaria pathogenesis","volume":"41","author":"Rasti","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.tmrv.2023.150748_bib0041","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrneurol.2009.23","article-title":"Diagnosis and management of the neurological complications of falciparum malaria","volume":"5","author":"Mishra","year":"2009","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.tmrv.2023.150748_bib0042","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.3389\/fimmu.2018.02016","article-title":"Cerebral Malaria in Mouse and Man","volume":"9","author":"Ghazanfari","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.tmrv.2023.150748_bib0043","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.pt.2009.05.012","article-title":"Genetic and genomic analyses of host-pathogen interactions in malaria","volume":"25","author":"Bongfen","year":"2009","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.tmrv.2023.150748_bib0044","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s00335-018-9752-9","article-title":"Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei","volume":"29","author":"Torre","year":"2018","journal-title":"Mamm Genome"},{"key":"10.1016\/j.tmrv.2023.150748_bib0045","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12936-016-1317-3","article-title":"Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria","volume":"15","author":"Moradin","year":"2016","journal-title":"Malar J"},{"key":"10.1016\/j.tmrv.2023.150748_bib0046","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.pt.2005.06.010","article-title":"Genetic resistance to malaria in mouse models","volume":"21","author":"Hernandez-Valladares","year":"2005","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.tmrv.2023.150748_bib0047","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1182\/blood-2006-09-018069","article-title":"Malarial anemia: of mice and men","volume":"110","author":"Lamikanra","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2023.150748_bib0048","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1128\/IAI.02586-14","article-title":"THEMIS is required for pathogenesis of cerebral malaria and protection against pulmonary tuberculosis","volume":"83","author":"Torre","year":"2015","journal-title":"Infect Immun"},{"key":"10.1016\/j.tmrv.2023.150748_bib0049","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/sj.gene.6364069","article-title":"Phenotypic expression of pyruvate kinase deficiency and protection against malaria in a mouse model","volume":"5","author":"Min-Oo","year":"2004","journal-title":"Genes Immun"},{"key":"10.1016\/j.tmrv.2023.150748_bib0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bcmd.2007.03.003","article-title":"Pyruvate kinase deficiency: correlation between enzyme activity, extent of hemolytic anemia and protection against malaria in independent mouse mutants","volume":"39","author":"Min-Oo","year":"2007","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.tmrv.2023.150748_bib0051","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng1260","article-title":"Pyruvate kinase deficiency in mice protects against malaria","volume":"35","author":"Min-Oo","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.tmrv.2023.150748_bib0052","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1182\/blood.V89.10.3847","article-title":"Molecular characterization of PK-LR gene in pyruvate kinase-deficient Italian patients","volume":"89","author":"Zanella","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2023.150748_bib0053","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2141.2005.05527.x","article-title":"Red cell pyruvate kinase deficiency: molecular and clinical aspects","volume":"130","author":"Zanella","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2023.150748_bib0054","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1056\/NEJMoa072464","article-title":"Pyruvate kinase deficiency and malaria","volume":"358","author":"Ayi","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2023.150748_bib0055","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/605843","article-title":"Adenosine triphosphate depletion of erythrocytes simulates the phenotype associated with pyruvate kinase deficiency and confers protection against Plasmodium falciparum in vitro","volume":"200","author":"Ayi","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmrv.2023.150748_bib0056","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/gene.2011.54","article-title":"Genetic diversity in human erythrocyte pyruvate kinase","volume":"13","author":"Berghout","year":"2012","journal-title":"Genes Immun"},{"key":"10.1016\/j.tmrv.2023.150748_bib0057","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144555","article-title":"Modulation of Malaria Phenotypes by Pyruvate Kinase (PKLR) Variants in a Thai Population","volume":"10","author":"van Bruggen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.tmrv.2023.150748_bib0058","article-title":"Hematologic and systemic metabolic alterations due to Mediterranean class II G6PD deficiency in mice","volume":"6","author":"D'Alessandro","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.tmrv.2023.150748_bib0059","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001339","article-title":"G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map","volume":"9","author":"Howes","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/j.tmrv.2023.150748_bib0060","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1178849","article-title":"Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians","volume":"326","author":"Louicharoen","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.tmrv.2023.150748_bib0061","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/313793a0","article-title":"Adaptation of Plasmodium falciparum to glucose 6-phosphate dehydrogenase-deficient host red cells by production of parasite-encoded enzyme","volume":"313","author":"Usanga","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.tmrv.2023.150748_bib0062","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1073\/pnas.80.1.298","article-title":"Glucose-6-phosphate dehydrogenase deficiency inhibits in vitro growth of Plasmodium falciparum","volume":"80","author":"Roth","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2023.150748_bib0063","first-page":"159","article-title":"Genetic variation in the host and adaptive phenomena in Plasmodium falciparum infection","volume":"94","author":"Luzzatto","year":"1983","journal-title":"Ciba Found Symp"},{"key":"10.1016\/j.tmrv.2023.150748_bib0064","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1172\/JCI112412","article-title":"Ribose metabolism and nucleic acid synthesis in normal and glucose-6-phosphate dehydrogenase-deficient human erythrocytes infected with Plasmodium falciparum","volume":"77","author":"Roth","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tmrv.2023.150748_bib0065","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/oxfordjournals.bmb.a071749","article-title":"The interaction of malaria parasites with red blood cells","volume":"38","author":"Pasvol","year":"1982","journal-title":"Br Med Bull"},{"key":"10.1016\/j.tmrv.2023.150748_bib0066","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0014-4894(84)90097-3","article-title":"Plasmodium falciparum: thiol status and growth in normal and glucose-6-phosphate dehydrogenase deficient human erythrocytes","volume":"57","author":"Miller","year":"1984","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.tmrv.2023.150748_bib0067","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/280245a0","article-title":"Oxidant damage mediates variant red cell resistance to malaria","volume":"280","author":"Friedman","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.tmrv.2023.150748_bib0068","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1182\/blood.V92.7.2527","article-title":"Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency","volume":"92","author":"Cappadoro","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2023.150748_bib0069","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0014-4894(90)90071-J","article-title":"Plasmodium falciparum: ATP\/ADP transport across the parasitophorous vacuolar and plasma membranes","volume":"71","author":"Choi","year":"1990","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.tmrv.2023.150748_bib0070","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.molbiopara.2010.09.001","article-title":"Central carbon metabolism of Plasmodium parasites","volume":"175","author":"Olszewski","year":"2011","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.tmrv.2023.150748_bib0071","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s12015-018-9811-3","article-title":"Genome editing in induced pluripotent stem cells using CRISPR\/Cas9","volume":"14","author":"Ben Jehuda","year":"2018","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.tmrv.2023.150748_bib0072","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1089\/scd.2019.0132","article-title":"Enhanced ex vivo generation of erythroid cells from human induced pluripotent stem cells in a simplified cell culture system with low cytokine support","volume":"28","author":"Bernecker","year":"2019","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.tmrv.2023.150748_bib0073","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev-immunol-101721-065201","article-title":"Reconciling mouse and human immunology at the altar of genetics","volume":"41","author":"Gros","year":"2022","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.tmrv.2023.150748_bib0074","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1128\/AAC.01719-09","article-title":"Cysteamine, the molecule used to treat cystinosis, potentiates the antimalarial efficacy of artemisinin","volume":"54","author":"Min-Oo","year":"2010","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088779632300038X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088779632300038X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:20:42Z","timestamp":1760138442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088779632300038X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S088779632300038X"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2023.150748","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biphosphoglycerate Mutase: A Novel Therapeutic Target for Malaria?","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2023.150748","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"150748"}}